Exercise training to reduce cardiovascular risk in patients with metabolic syndrome and type 2 diabetes mellitus: How does it work?

Nicolle Kränkel(Leipzig Heart Institute), Hareld Kemps(Radboud University Nijmegen), Dominique Hansen, Erik Ekker Solberg(Ullevål Sykehusapotek), Martin Bahls(Universitätsmedizin Greifswald), Marcus Dörr(University of Freiburg), Luis Serratosa(Hospital Universitario Quirónsalud Madrid), Volker Adams(University Hospital Carl Gustav Carus), Emeline M. Van Craenenbroeck(Antwerp University Hospital)
European Journal of Preventive Cardiology
October 15, 2018
10.1177/2047487318805158
Cited by 55

Related Papers

2024 ESC Guidelines for the management of chronic coronary syndromes
|European Heart Journal|2024|2.3k
2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease
|European Heart Journal|2020|1.8k
SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe
|European Heart Journal|2021|1.7k
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial
|The Lancet|2020|1.2k
Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol
|European Heart Journal|2005|1.1k